NCT06851559Phase 2Active not recruiting

A Study in Adult Participants With EoE to Evaluate Vonoprazan 20 mg Compared to Placebo After 12 Weeks and to Evaluate Vonoprazan 20 mg Up to 24 Weeks

Study sponsor: Phathom Pharmaceuticals, Inc. · PHAT

Primary completion is the date data collection ends for the main study measures, not when results are published.

Primary completion2026-09-11Actual
Enrollment · participants95Actual
Source updated2026-10-13Last update listed in the registry record

Changes to this trial

Last 12 months
Filters
Clear filters

· 2 fields changed

Completion date type changed

Before: Estimated. After: Actual.

Primary completion date changed

Before: Oct 2026. After: 11 Sep 2026.

Check registry source

· 4 fields changed

Participant count type changed

Before: Estimated. After: Actual.

Enrollment · participant count changed

Before: 80 participants (planned). After: 95 participants (actual).

Primary completion date changed

Before: Dec 2026. After: Oct 2026.

Recruitment status changed

Before: Recruiting. After: Active not recruiting.

Check registry source

Explore older trial changes

Upgrade to Pro to see the full available history for this trial.

Upgrade to Pro Illustrative preview